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Genome-Wide Interaction-Based Association of
Human Diseases — A Survey
Xuan Guo, Ning Yu, Feng Gu, Xiaojun Ding, Jianxin Wang , and Yi Pan
Abstract: Genome-Wide Association Studies (GWASs) aim to identify genetic variants that are associated with
disease by assaying and analyzing hundreds of thousands of Single Nucleotide Polymorphisms (SNPs). Although
traditional single-locus statistical approaches have been standardized and led to many interesting findings, a
substantial number of recent GWASs indicate that for most disorders, the individual SNPs explain only a small
fraction of the genetic causes. Consequently, exploring multi-SNPs interactions in the hope of discovering more
significant associations has attracted more attentions. Due to the huge search space for complicated multilocus interactions, many fast and effective methods have recently been proposed for detecting disease-associated
epistatic interactions using GWAS data. In this paper, we provide a critical review and comparison of eight popular
methods, i.e., BOOST, TEAM, epiForest, EDCF, SNPHarvester, epiMODE, MECPM, and MIC, which are used
for detecting gene-gene interactions among genetic loci. In views of the assumption model on the data and
searching strategies, we divide the methods into seven categories. Moreover, the evaluation methodologies,
including detecting powers, disease models for simulation, resources of real GWAS data, and the control of false
discover rate, are elaborated as references for new approach developers. At the end of the paper, we summarize the
methods and discuss the future directions in genome-wide association studies for detecting epistatic interactions.
Key words: Single Nucleotide Polymorphism (SNP); genome-wide association; epistasis; epistatic interaction;
complex disease
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Introduction

Genome-Wide Association Studies (GWASs) have been
proven to be a powerful tool for investigating the
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genetic architecture of human disease over the last ten
years. It is a genomic and statistical inference study
that involves statistical tests to measure and analyze
DNA sequence variations in different individuals to
see if any variant is associated with a trait. The
ultimate goal of GWAS is to use genetic risk factors
to predict who is at risk and to identify the biological
underpinnings of disease susceptibility for developing
new preventions and treatment strategies[1] . The first
exciting finding of GWAS is on Age-related Macular
Degeneration (AMD), which identifies the Complement
Factor H gene as a major risk factor[2] . The associated
Complement Factor H gene demonstrates not only
the DNA sequence variations but also the biological
basis for the effect. Another successful application
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of GWAS is in the area of pharmacology, which
heavily depends on understanding the biological basis
of genetic effects. The goal of pharmacogenetics is to
identify associated DNA sequence variations with drug
metabolism and efficacy as well as adverse effects. Take
warfarin for example, which is a blood-thinning drug
that helps prevent blood clots in patients. A recent
validation studies reveal that warfarin dosing can be
largely influenced by the DNA sequence variations in
several genes[3] . Accordingly, GWAS is increasingly
used to identify biological pathways and underlying
networks of complex diseases[4] . It has led to the
exciting era of personalized medicine and personal
genetic testing aiming to tailor healthcare for individual
patients based on their genetic background and other
biological features.
The modern unit of genetic variation is the Single
Nucleotide Polymorphism (SNP) which refers to a
single base change in a DNA sequence with an
usual alternative of two possible nucleotides at a
given position[5] . SNPs are the most common and
abundant form of genetic variation amongst the human
population. It is estimated that on average there
is an SNP per every 300 bp of DNA, and about
11 million SNPs are on the whole genome of human
species. However, due to a genetic phenomenon called
Linkage Disequilibrium (LD) and the large majority
of them with minor impacts on biological systems, it
is not necessary to study all the SNPs[6, 7] . The basic
functional consequence of SNPs is amino acid change,
which leads to the fluctuation of mRNA transcript
stability and the transcription factor binding affinity
through the central dogma[8] . In general, there are two
commonly occurring base-pair possibilities for the same
sequence location in a population. In this case, we say
that the SNP has two alleles. An SNP is assigned a
minor allele frequency or a frequency of less common
allele when it is observed less frequently in a particular
population. For example, if 20% of a population has the
Cytosine allele versus the more common allele or the
major allele, which takes up 80% of the population, then
this SNP has a minor allele (C) with frequency of 0.2.
In the last two decades, extensive computational
efforts have been provided to study the functional
and structural consequences of the SNPs[9] . Highthroughput chip based microarray technology has
made GWAS possible for assaying one million or
more SNPs. Currently, two primary platforms from
Illumina (San Diego, CA) and Affymetrix (Santa
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Clara, CA) have been used for most GWASs. The
Illumina platform uses a bead-based technology,
which features better specificity at a little high
cost, with slightly longer DNA sequences to detect
alleles. The Affymetrix platform prints short DNA
sequences as a spot on the chip that recognizes a
specific SNP allele by differential hybridization of the
sample DNA. More details of these two competing
technologies can be found in Ref. [10]. By far, over
600 GWASs have been launched for 150 diseases and
traits. In addition, aiming to examine the relationship
between human genome sequence variation and the
associated disease phenotypes, various international
consortia are collecting information about variations
in human genome, including HapMap consortium,
Human Variation Project, 1000 Genomes Project, and
Wellcome Trust Case Control Consortium (WTCCC).
The phenotypes in GWAS can be classified as
either categorical (often binary case/control) or
quantitative. Although quantitative traits are preferred
and they improve power of detecting a genetic effect
from the statistical perspective, well established
quantitative measures are not available for many
disease traits. Consequently, individuals in standard
studies are usually categorized to binary variable. In
this review, we focus on the methods for genome-wide
case/control studies. Note that existing methods
can handle quantitative traits by discretizing a
continuous phenotype with minor modification. A
routine in GWAS is the comparison between two
groups of individuals: One has a higher prevalence of
susceptibility alleles for interested trait, and another
has a lower prevalence of such alleles[11] . The primary
analysis paradigm for GWAS is dominated by the
analysis on the susceptibility of individual SNPs,
which can only explain a small part of genetic causal
effects for complex diseases[12] . As a matter of fact,
single locus-based approaches are insufficient to detect
all interacting genes, especially for those with small
marginal effects. For better understanding underlying
causes of complex disease traits, identifying joint
genetic effects (epistasis) across the whole genome has
attracted more attentions[13] . The concept of epistasis[14]
was introduced around 100 years ago. It was referred
as an extension of the concept of dominance for
alleles within the same allelomorphic pair[15] . In recent
literatures, epistasis has been defined as the interaction
among different genes (SNPs)[16] . Many studies
have demonstrated that the epistasis is an important
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contributor to genetic variation in complex diseases,
such as asthma, breast cancer[17] , diabetes, coronary
heart disease[18] , and obesity[19] . In this paper, we also
refer epistasis as a gene-gene interaction. Genome-wide
association studies provide an enormous opportunity to
identify high-order epistatic interactions among genetic
variants throughout the genome. Without loss of
generality, we consider high-order epistatic interactions
or epistasis as the statistically significant associations
of k-SNP modules (k > 2) with phenotypes.
Two challenges arise from finding high-order
epistatic interactions associated with an interested trait
among a large number of SNPs. The first comes
from the combinatorial nature of the problem that the
number of SNP combinations exponentially increases
as the order goes up. Given a GWAS dataset with
hundreds of thousands of SNPs, using brute-force
approaches to examine all combinations of SNPs
is computationally challenging, and even requires
specialized hardwares[20-22] . For example, in order to
detect pairwise interactions from 500 000 SNPs, which
is a typical size of data generated by the Affymetrix
platform, with thousands of samples genotyped, about
1:25  1011 statistical tests require to be proceeded. The
second challenge concerns the statistical power for
high-order SNP combination search. Since the huge
number of hypothesis tests are often conducted on
limited sample sizes with high degree of freedom,
many false epistases are significantly associated
with a disease trait by random chance[23, 24] . Many
computational algorithms have been proposed to
overcome these two challenges. Based on their search
strategies, existing approaches for searching epsitasis
can be grouped into four broad categories: exhaustive
search, stepwise search, stochastic search, and heuristic
search. The naive solution to tackle the problem
is exhaustive search by enumerating all possible
combinations of multiple loci and performing desired
interaction tests for each combination. Marchini et
al.[13] showed that it is computationally possible to
test two-locus associations allowing for interactions in
GWAS based on current computation resources. Instead
of explicitly enumerating all possible combinations
of k-locus, stepwise search strategies select a subset
of SNPs or combinations of SNPs based on some
low-order statistic tests (or measures), then extend
them to higher order interactions if it is statistically
possible. Similar to stepwise searching, stochastic
methods use random sampling procedures to search

the space of interactions, and the performance relies
on random chances to select phenotype-associated
SNPs. With the number of SNPs going higher, the
chances of correct hit drop accordingly. Heuristic
methods use some heuristics to avoid exhaustive
searches to obtain locally optimal solutions based on
available information. Another way to categorize the
epistatic interaction methods depends on the usage
of models, i.e., model-based methods and model-free
methods. By assuming a statistical model between
phenotypes and genotypes, model-based methods use
the case/control data to fit models and select the best
model to rank the SNP modules. In contrast, model-free
methods only examine the statistics of each possible
epistasis associated with phenotypes rather than put
prior assumption on the observed data. More details of
the categorized methods are provided in Section 4.
Considering the wide variety of algorithms
and techniques used in the detection of epistatic
interactions, this paper is dedicated to offering a clear
and complete picture of the epistasis detection by
discussing and summarizing different tools according
to their features. The organization of this article is
as follows. We first give a statement of the problem
in Section 2. Then we give two basic methods for
searching epistatic interactions in view of model-based
and model-free in Section 3. Total eight methods
are elaborated with critial comments at the end of
each discussion in Section 4 in respect of searching
strategies. We describe the evaluation methodologies
in Section 5 including the calculation of statistical
power, the control for false discovery rate, resources
of synthetic and real GWAS data, and a summary of
current tools for detecting epistatic interactions. Finally,
we discuss the future research directions of high-order
epistasis detection in Section 6.

2

Problem Statement

Two types of data are collected in GWAS: genotype
data, which encodes the genetic variants of individuals,
and phenotype data that indicates the affected statuses
of individuals. Like the methods reviewed in this paper,
we only consider bi-allelic SNPs, which means that an
SNP has only two alleles. The SNP is termed as a minor
allele if the allele occurs less frequently, otherwise it
is termed as a major allele if the allele occurs more
frequently. Usually, we use lowercase letter to denote
the minor allele and uppercase letter to denote the major
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allele, like a and A; so the two alleles form three
genotypes, AA, Aa, and aa, and they can be encoded
as 0, 1, and 2 in raw data. For phenotype data, the
binary variable is used that 0 indicates unaffected and
1 indicates affected.
The goal of detection of epistatic interactions
is to identify k-SNP .k > 2/ modules significantly
associated with the phenotype. Furthermore, epistatic
interactions can be classified into two types: epistasis
displaying Marginal Effects (eME) and epistasis
displaying No Marginal Effects (eNME)[25] . More
details can be found in Section 5.2. Basically, there
are two challenges in searching epistasis: First, the
total number of tests grows exponentially as k
increases, leading to the inability of exhaustive search
to examine all the combinations. For example, using
epiSNP[26] to emulate and calculate all the twolocus epistatic interactions on a GWAS dataset with
1 000 000 SNPs will take 5 years on a 2.66 GHz
single processor. Second, because a huge number of
hypotheses are tested using limited samples, a large
proportion of significant associations are expected to be
false positives. Therefore, retaining the statistical power
while reducing false positive rate is another important
issue.

3

Methods in View of Model-Based and
Model-Free

There are two ways to categorize the methods for
detecting epistatic interaction: One is according to the
assumption on the observed data; another is according
to the searching strategy. We will cover the latter one
in next section. An overview of recently developed
43 methods is depicted in Fig. 1, and eight of them
with name in bold are reviewed and discussed in
Section 4. If a predefined statistical model is set up
between phenotypes and genotypes, we say that it is
a model-based approach in which some parameters
require to be estimated; otherwise it is a model-free
method that no prior assumption is made on the data
or the model.
In order to give an overview of model-based and
model-free methods on detecting epsitasis, we describe
two routines in the following section: (1) model fitting
using logistic regression models and (2) Pearson’s 2
test of goodness of fit. Obviously, the former is modelbased, and the latter is model-free. Assuming that there
are L SNPs and N samples, we use S to denote the
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ordered set of the L SNPs, si to denote the i -th SNP
in S (i 2 Œ1; L), and Y to denote the class label
(1 for case and 0 for control). For the analysis of
two-locus epistatic interactions, we need to collect a
contingency table (shown in Table 1), where nijy is the
count of individuals with genotype sa D i , sb D j , and
phenotype Y D y.
For the model-based methods, the model defining
the epistasis via logistic regression models must be
established at first. The logistic regression model with
both main effect (marginal effect) terms and interaction
terms, i.e., the full model, has the following form:
P .Y D 1jsa D i; sb D j /
log
D
P .Y D 0jsa D i; sb D j /
s
s s
ˇ0 C ˇisa C ˇj b C ˇija b
(1)
The null logistic regression model without main
effect term or interaction terms has the following form:
P .Y D 1jsa D i; sb D j /
log
D ˇ0
(2)
P .Y D 0jsa D i; sb D j /
There are nine coefficients in Eq. (1) and one
coefficient in Eq. (2). We denote the log-likelihood
of the full model as LF and the log-likelihood of the
null model as LN . According to the likelihood ratio
test, the effect of epistasis in this paper is defined as
the difference between two log-likelihoods of models
in Eqs. (1) and (2). By evaluating the values at their
Maximum Likelihood Estimations (MLEs), i.e., LOF
LON , we are able to estimate epistasis effect based on
the departure of observed data from the null model
naturally.
For the model-free method using Pearson’s 2 test of
goodness of fit, the following steps are conducted: (1)
Collect the contingency table as shown in Table 1; (2)
Obtain the p-value using 2 statistic (Eq. (3)) with 8
degrees of freedom[27] .
n
X
.Oi Ei /2
(3)
2 D
Ei
i D1

where n is the count of genotype combinations by
giving a set of SNPs. The observed frequency O is
Table 1

Y =0

Y =1

The genotype counts in cases and controls.
sb =0
sb =1
sb =2
sb =0
sb =1
sb =2

sa =0
n000
n010
n020
n001
n011
n021

sa =1
n100
n110
n120
n101
n111
n121

sa =2
n200
n210
n220
n201
n211
n222
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Fig. 1

Classification of the methods that detect epistasis.

corresponding to the count of the individual with a
certain genotype combinations and a class label. SNP
modules with p-value larger than a predefined threshold
are reported as significant epistasis. Note that not all
model-free methods are using the above described
approaches, but they share the same feature that similar
tests are applied for detection without any estimation of
parameters of models.

4

Methods in View of Searching Strategies

According to the search strategy, existing approaches
for searching epistatic interactions can be grouped
into four broad categories, exhaustive search, stepwise

search, stochastic search, and heuristic approaches. In
review of recent literatures, we identify 43 methods
used to detect epistasis, excluding specializations,
tweaks, and simply paralleled methods. In the
following sections, we scrutinize eight methods in
these four categories, and point out their advantages
and disadvantages.
4.1

Exhaustive searching methods for detecting
epistatic interactions

The naive solution to tackle the problem of detecting
epistatic interaction is exhaustive search using 2
test, exact likelihood ratio test or entropy-based test
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for all modules of multiple-locus. Marchini et al.[13]
show that it is computationally possible to test twolocus associations allowing for interactions in GWAS
based on current computing capability. Examples in
exhaustive search, like MDR[17] and its extensions,
utilize repeated cross-validations and permutation
tests to evaluate accuracy and significance of
classification. A major barrier for exhaustive search is
the intensive computation, and thus parallel computing
was adopted to further speed up the analysis of genegene interactions. For example, GBOOST[28] is a
GPU framework based implementation of BOOST,
and PIAM is developed by Liu et al.[29] , which
used the multi-thread to perform Genome-Wide
Interaction-Based Association (GWIBA) analysis for
exhaustive two-locus searches. However, finding higher
order (more than 2 loci) disease-related associations
is too computationally expensive to be feasible,
especially for large GWAS datasets with millions
SNPs. In this section, we use BOOST and Tree-based
Epistasis Association Mapping (TEAM) as examples
of exhaustive searching methods. The overview and
resource information of method falling into exhaustive
search is shown in Table 2.
4.1.1

BOOST

BOOST is a model-based, exhaustive search method,
which is the abbreviation of “BOolean Operation-based
Screening and Testing”[20] . Indicated by the name, there
are two features of BOOST: First, a new boolean
representation is used to accelerate the collecting of
contingency table; Second, an upper bound for the
likelihood ratio test based on log-linear models and
Kirkwood superposition approximation[40] is used to
prune insignificant epistatic interactions. Instead of
using one row for each SNP, the boolean representation
uses three rows, with each row for one specific genotype
from 0 through 2. Each row consisted of two strings
of boolean values (0 or 1), one for control samples
and another for case samples. Each bit in the string
represented one individual, and its value was set to
1 if the individual had the corresponding genotype,
otherwise 0. By transforming the data representation
to the boolean type, the collecting of contingency
table information can be efficiently accomplished by
performing 64-bit AND operation in one instruction,
and the counting of “1” bits in a bit string can be treated
as hamming weight.
The interested interactions focused by BOOST is

Table 2
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Exhaustive search methods for detecting epistasis.

Model-based
Bayesian Network Minimum Bit Length score
(2010)[30]
BOOST
Boolean Operation-based Screening and
Testing (2009)[20] , http://bioinformatics.ust.hk/
BOOST.html
INTERSNP INTERSNP (2009)[31] , http://intersnp.meb.unibonn.de
TM
Tukey’s 1 d.f model for interaction (2006)[32]
FIM
Full Interaction Model (2005)[13] , http://www.
cbil.ece.vt.edu/ResearchOngoingSNP.htm
PLR
Restricted Partitioning Method (2004)[33]
BNMBL

Model-free
Genome Wide Interaction Search (2013)[34] ,
http://bioinformatics.research.nicta.com.au/gwis
iLOLi
Interacting Loci (2012)[35] , http://www4a.
biotec.or.th/GI/tools/iloci
TEAM
Tree-based Epistasis Association Mapping
(2010)[21] , http://www.csbio.unc.edu/epistasis/
download.php
COE
COE (2009)[36] , http://www.csbio.unc.edu/
epistasis/download.php
FastChi
FastChi (2009)[37] , http://www.csbio.unc.edu/
epistasis/download.php
FastAVOVA FastANOVA (2008)[38] , http://www.csbio.unc.
edu/epistasis/
epiSNP
epiSNP (2008)[26] , http://animalgene.umn.edu/
episnp/index.html
RPM
Restricted Partitioning Method (2004)[39]
CPM
Combinatorial Partitioning Method (2001)[18]
MDR
Multifactor
Dimensionality
Reduction
(2001)[17] , http://sourceforge.net/projects/mdr/

GWIS

not totally equivalent to the epistasis defined in this
review. In the terms of the logistic regression model,
the likelihood ratio test used in BOOST is based on the
deviance of difference between the full model and the
main effect model,
P .Y D 1jsa D i; sb D j /
s
D ˇ0 C ˇisa C ˇj b :
log
P .Y D 0jsa D i; sb D j /
BOOST denotes the log likelihood of the full model
under MLE as LOF , the log likelihood of the main effect
model under MLE as LOM , the log likelihood of loglinear saturated model as LOS , which was equivalent
to the full logistic regression model, and the log
likelihood of the homogeneous model as LOH , which is
equivalent to the main effect model. According to the
likelihood ratio test, interaction effects are measured
by the difference between two log likelihoods of the
main effect model and the full model evaluated at their
MLEs, i.e., .LOM LOF /. Directly using .LOS LOH / to
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test interactions in GWAS still has some difficulties,
because iterative methods are needed in model fitting
to compute LOH , which is computationally intensive
when hundreds of billions of SNP pairs were required
to test. The Kirkwood Superposition Approximation
(KSA) is used to approximate the homogenous
O 6 LOH /
association model to get a lower bound, .LKSA
of .LOS LOH /. The reason for the replacement is that the
O is straightforward and no iteration
calculation of LKSA
is involved. BOOST contains two stages: screening,
evaluates all pairwise interactions by using the KSA;
O / > , tests
testing, for each pair with 2.LOS LKSA
the interaction effect using the likelihood ratio statistic
2.LOS LOH /.
BOOST only focuses on detecting the eNME, i.e.,
epistasis displaying no marginal effects, so it achieves
high power when applied to simulated dataset with
only eNME. One weakness of BOOST is that it can
be only used to detect two-locus epistatic interaction,
although it runs very fast (it only takes 170 seconds to
analyze 10 000 SNPs with 5000 samples on a 3.0 GHz
CPU with 4 GB memory running the Windows XP
Professional system).
4.1.2

TEAM

TEAM[21] is a model-free, exhaustive search method
to detect two-locus epistatic interactions in GWAS.
TEAM is dedicated to address the heavy computation
aroused by the permutation test. Because many
SNPs are correlated, and their correlation structures
among genotype profiles can be preserved across
enumeration, permutation test is preferred over
simple Bonferroni correction. In permutation test,
we perform significance test each time when class
labels were shuffled. More details about permutation
test are covered in Section 5. Following the above
notations, the entire search space of two-locus
interaction is HLN.L 1/=2 with H different
permutations. Considering a moderate GWAS setting
that N D 1000, L D 100 000, and H D 1000, we
need to conduct 5  1015 pairwise tests. Obviously,
it is expensive to compute the contingency table for
every combination of SNPs on all permutations for
calculating the p-values.
Zhang et al.[21] stated that many statistics, such
as 2 test and likelihood ratio test, were defined as
the functions of the counts collected in contingency
table. In particular, calculating the two-locus test
value needed all 18 observed frequencies in two-

way contingency table (Table 1). The authors
proved that given an SNP pair and two singlelocus contingency tables of each SNP, once the value of
.n111 ; n121 ; n211 ; n222 / fixed, the two-locus test value
can be calculated for any permutations. In addition,
these four values can be determined incrementally
utilizing a Minimum Spanning Tree (MST) built on
SNPs. In the MST, the nodes were SNPs, and the
edges were the SNP pairs with weights indicating the
number of individuals having different genotypes. In
other words, the computation of a contingency table
in other permutations can be achieved by considering
only the individuals with different values, and they had
been represented as weights in MST. As it is costly to
construct an MST, TEAM constructed an approximate
MST instead.
The overall time complexity of TEAM is O.NLH C
NL2 C WT NH /, where O.NLH / is for generating
all single-locus contingency tables, O.NL2 / is for
building the minimum spanning tree, and O.WT NH /
is for updating the value of n111 ; n121 ; n211 ; and n222
for H permutations. Comparing to the complexity
of brute force approach O.NL2 H /, the performance
of TEAM was faster than the latter by an order of
magnitude. As TEAM does not presume any statistical
model, it is applicable to any test statistic, e.g., 2
test, exact likelihood ratio test, and entropy-based test,
based purely on contingency table information, and
to detect both eME and eNME. However, if there is
no close-form solution for calculating the statistic test
value, using the same framework in TEAM is still
computationally intensive when we deal with tons of
SNPs.
4.2

Stepwise searching methods for detecting
epistatic interactions

Although exhaustive search is computationally possible
to test all two-locus epistatic interactions for a moderate
size of GWAS data, it requires huge computation
time, and loses statistic power when searching higherorder interactions as discussed in Section 2. Instead
of explicitly enumerating all possible combinations
of k-locus, stepwise search approaches first select a
subset of SNPs based on single-locus tests or modelfree measures, then conduct tests for multi-locus
interactions on the selected subset of SNPs. Compared
to exhaustive approaches, stepwise algorithms usually
are much faster, and may perform reasonably well
for disease associated interactions when the marginal
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effects exist. As shown in a recent theoretical study[41] ,
the possibility that a high-order (size-k) combination
with strong differentiation between case and control
groups displaying zero differentiation in all of its
subsets decreases dramatically when k increases
(generally become impossible for k greater than
5). However, since it removes a considerable portion
of SNPs, stepwise search may not be able to find
interactions involving loci with small or no marginal
effects. The methods are shown in Table 3.
4.2.1

epiForest

Jiang et al.[43] proposed a stepwise approach,
called epiForest (detection of epistatic interactions
using random Forest), for detecting multi-locus
epistasis. epiForest uses SWSFS (Sliding Window
Sequential forward Feature Selection) algorithm to
select a small set of SNPs as candidates, and then
statistically tests up to three-way interactions on the
candidates.
In epiForest, the GWAS can be treated as a binary
classification problem where cases are positive samples
Table 3

Stepwise search methods for detecting epistasis.

RanJungle

epiForest

HapForest

FITF
TSTLM
DCHE

EDCF

PatternRec

BGTA
ITMDR

Model-based
Random Forests for high-dimensional data
(2010)[42] , http://www.randomjungle.org/rjungle/
rjunglenews
Random forest for the detection of epistatic
interactions
(2009)[43] ,
http://bioinfo.au.
tsinghua.edu.cn/epiForest
Forest-based
approach
to
identifying
gene-gene interactions (2007)[44] , http://
c2s2.yale.edu/software packages/HapForest/
Focused Interaction Testing Framework
(2006)[45] , http://hydra.usc.edu/fitf
Two-Stage Two-Locus Models (2006)[46]
Model-free
Dynamic Clustering for High-order genomewide Epistatic interactions detecting (2014)[47] ,
http://www.cs.gsu.edu/xguo9/DCHE.html
Epistasis Detector based on the Clustering
of relatively Frequent items (2012)[48] ,
http://www.cs.ucr.edu/minzhux/EDCF.zip
Genotype Pattern based on Difference
Frequencies
(2009)[49] ,
http://www.
genemapping.cn
Backward
Genotype-Trait
Association
(2006)[50] , http://statgene.stat.columbia.edu
Information Theory and MDR (2006)[51] ,
http://www.cbil.ece.vt.edu/ResearchOngoingSNP.
htm
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and controls are negative samples, and it utilizes the
random forest for the classification. The SNP markers
are used as categorical features with three possible
values in the classification formulation. The random
forest is an ensemble learning methodology originated
by Breiman[52] . The basic idea of ensemble learning is
to boost the performance of a number of weak learners
via a voting scheme, where a weak learner can be an
individual decision tree, a single perceptron/sigmoid
function, or other simple and fast classifiers. In order to
measure the contribution of an SNP to the classification
performance, epiForest uses the gini importance, which
is defined as the summation of all gini decrease of a
centain feature over all trees in the forest. It shows
that the gini importance and the raw importance are
very consistent[52] , and the computation cost of the gini
importance is much more economic[43] .
There are two stages of epiForest. On the first
stage, the random forest is built on all SNPs to
classify the GWAS data, and the objective is to
obtain the contribution for every SNP measured by
gini importance. SWSFS algorithm greedily searches
for a small subset of SNPs that could minimize
the classification error. It adds one SNP at a time
by the order from the most significant SNP to the
least significant one. SWSFS selects a small set of
l .<< L, the total number of SNP markers) candidate
SNPs that have the most significant contribution to
the discrimination of cases against controls. On the
second stage, a hierarchical procedure is adopted for
one-, two-, and three-way statistical tests to declare
the statistical significance that the candidate SNPs are
associated with the disease. In the one-way tests, the
B statistic proposed by Zhang and Liu[53] is applied to
every candidate SNP. Given a predefined significance
level ˛ (e.g., 0.05), all SNPs whose p-values are
more significant than ˛ after Bonferroni corrections
for L tests, are reported. In the two-way tests, the
B statistic was also used, and interactions whose pvalues were less than ˛ after Bonferroni corrections
for L.L 1/=2 tests, are reported. If both two SNPs
in two-locus interaction have already been detected
in the one-way tests, further interaction tests will be
skipped, otherwise they are considered for two- and
three-way interaction tests. Similarly, in the three-way
tests, the B or conditional B statistics were applied to
all three-way interactions of the candidates, and those
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with p-values less than ˛ after Bonferroni corrections
for L.L 1/.L 2/=6 tests are reported.
With a limit on the size of subset of most
important SNPs, the random forest is constructed
very fast. epiForest is capable to detect up to
three-way epistatic interactions including eME and
eNME. However, the detection of epistasis is not as
the same as the feature selection process by tradition
classification. Phenotype associated combinations of
SNPs may not be the only factor leading to the disease
effects. Therefore, merely relying on the decision tree,
epiForest is insufficient to capture all the SNPs linked
to the disease status.
4.2.2

EDCF

Xie et al.[48] proposed a stepwise search algorithm
called EDCF to detect multi-locus epistatic interactions
in genome-wide case/control studies. The number
of SNPs in current GWAS ranges from several
hundreds of thousands to a few millions. For
interactions involving k loci .k > 3/, it is impractical
to exhaustively
search the whole space since there
!
L
are
possible combinations. Therefore, based
k
on the assumption that the subsets of significant
interaction modules were possibly significant, EDCF
selects top-dfs significant .k 1/-locus modules for
k-locus interaction test. EDCF starts with searching
for the top-dfs significant two-locus interaction (where
fs > 1 is a scale factor), and EDCF evaluates all 2locus combinations (k D 2). It recursively searched the
interaction space with the top selected SNPs until k
reaches user defined value. Due to the large number of
reported significant interactions, biologists may only be
interested in the d most significant ones, so only top-d
interactions are generated by EDCF.
To measure the statistic significance of epistasis, the
test utilized by EDCF is Pearson’s 2 test. In order
to give a reasonable elevation of SNP combinations,
EDCF partitions all 3k genotype combinations for klocus into three groups, defined as G0 , G1 , and G2 . G0
contains all combinations that occur significantly more
frequently in cases than in controls (presumably
high-risk combinations); G2 contains those who
occur significantly more frequently in controls than
in cases (presumably low-risk combinations); and
G1 contains the remaining genotypes. To group
the genotype combinations, EDCF assumes the
population po with the same genotype followed a

Binomial distribution. For the Binomial distribution, the
parameter n equals to the total count of po, and another
parameter p equals to the ratio of case or control count
over n. To obtain high-risk combinations, EDCF uses
case count over n, while it used control count over n to
obtain low-risk combinations. Given a significance level
˛s , let Ta and Tu denote the critical value corresponding
to ˛s for cases and controls, respectively. The genotype
is treated as high-risk if the count of cases in this
genotype is larger than Ta . Similarly, the genotype
is treated as low-risk if the number of controls in
this genotype was larger than Tu . Once all genotype
combinations for k SNPs have been grouped into G0 ,
G1 , and G2 , EDCF collects a 3  2 contingency
table, where the rows represented three groups and
the columns represented two class labels for case and
control. The 2 statistic with 2 degrees of freedom[54] is
used to measure the significance of the interactions.
By combining the advantages of the 2 test
and high/low-risk genotype combinations, EDCF is
an effective and efficient algorithm for detecting
epistatic interactions for GWAS, especially when
interactions contained strong main effects. Comparing
to the model-based exhaustive search approaches,
like BOOST, extensive experiments on simulated data
illustrate that EDCF tends to lose certain powers
on detecting embedded disease models without main
effects (eNME)[48] .
4.3

Stochastic searching methods for detecting
epistatic interactions

Instead of explicitly enumerating all possible
combinations of k-locus,
stochastic methods
use random sampling procedures to search the
space of interactions. Among them, Bayesian
Epistasis Association Mapping (BEAM)[53] is one
representative. BEAM takes case-control genotypes as
input, and iteratively uses the Markov Chain Monte
Carlo (MCMC) approach to calculate the posterior
probability of a locus or multiple loci associated
with the disease. Tang et al.[55] extended BEAM
in their epistatic MOdule DEtection (epiMODE)
method. epiMODE uses Gibbs sampling and a
reversible jump MCMC procedure to search for
significant epistatic modules. A basic framework of
stochastic search strategy can be generalized as follows.
Given a set of states (or configurations) X D
fX1 ;    ; XM g and a function, Eval. /, that evaluates
each configuration, four basic steps are employed in
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stochastic search to find X  such that Eval.X  / is
greater than all Eval.Xi / for all other possible values
of Xi :
 Step 1 Initialize the configuration X .
 Step 2 Calculate the function value, Eval.X /.
 Step 3 Randomly select X 0 in the neighbors of X .
 Step 4 Obtain the new function value, Eval.X 0 /;
if Eval.X 0 / is better than Eval.X /, set X to X 0 ; go
to Step 2 until reach the maximum iteration count.
Particularly, the states are the assignments of
SNPs (jointly associated with disease or not) and
the function can be the posterior probability from
predefined models. It is necessary to note that existing
methods falling to stochastic search are all modelbased as shown in Table 4. In the following, we use
SNPHarvester and epiMODE to illustrate the basic idea
in stochastic search for detecting epistasis.
4.3.1

SNPHarvester

Yang et al.[56] proposed a method, SNPHarvester,
using a path selection procedure to sample the
searching space. SNPHarvester first identifies diseaseassociated SNP groups from thousands of SNPs. It
assumes that multiple epistatic interactions rather than
a single one are expected to be found due to the
sophisticated regulatory mechanism encoded in the
human genome. SNPHarvester then generates multiple
paths with a generic score function to identify multiple
significant SNP groups. After that, L2 penalized logistic
regression model[59] is used as a post-processing step
to extract epistasis from selected SNP groups. The
screening process based on path selection greatly
reduces the number of SNPs for further statistic
measure, and it makes SNPHarvester possible to
directly apply to large GWAS dataset for detecting highTable 4

Stochastic search methods for (model-based)
detecting epistasis.

epistatic MOdule DEtection (2009)[55] , http://
bioinfo.au.tsinghua.edu.cn/epiMODE/
SNPHavester Filtering-based approach for detecting
epistatic interactions (2009)[56] , http://
bioinformatics.ust.hk/SNPHarvester.html
LogicFS
LogicFS (2008)[57] , http://bioconductor.org/
packages/2.4/bioc/html/logicFS.html
BEAM
Bayesian Epistasis Association Mapping
(2007)[53] , http://www.fas.harvard.edu/junliu/
BEAM/
MCLR
Monte Carlo Logic Regression (2005)[58] ,
http://cran.r-project.org/web/packages/
LogicReg/index.html

epiMODE
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order epistatic interaction.
Before giving the details of SNPHarvester, we need
to introduce its assumption used by it. SNPHarvester
partitions the L SNP markers into three classes as
follows[56] :
 Class 0: SNPs are unassociated to the disease.
 Class 1: SNPs influence the disease risk
independently, i.e., they show marginal effects.
 Class 2: SNPs contribute little effects to the
disease risk individually but influence the disease
risk jointly.
SNPHarvester consists of two steps: the filtering and
the model-fitting steps. In the filtering, it randomly
initializes the starting point of each path, and
generates the path by a local search algorithm called
PathSeeker. PathSeeker uses the score function to
measure the association between a k-SNP group and
the phenotype, then records the SNP group whose score
exceeds a fixed threshold. It adopts the 2 value as
the score function, and the threshold is determined
by Bonferroni correction. PathSeeker first removes
significant single SNPs according to their 2 test
values, because SNPHarvester is only interested in
epistatic interactions that have weak main effects but
significant joint effect. Then it randomly picks k-SNP
to form an active set S D fSNP1 ; SNP2 ;    ; SNPk g,
and leaves the rest of the SNPs to form a candidate
set Sc for the next random selection. A swapping
operation is applied between S and Sc to switch two
SNPs, SNPi 2 S; SNPj 2 Sc , if the new k-SNP group
achieves better 2 test value. For generating one kSNP group, PathSeeker needs to try a total of k.n
k/ combinations. The identified group with the local
optimum 2 test value is removed from the L SNPs. In
next iteration, PathSeeker continues to select k SNPs
to form another active set, and the rest n 2k SNPs
form a candidate set. The time complexity to generate m
groups is O.kLm/, which is affordable even when there
were > 100 000 SNPs. The identified m k-SNP groups
are employed for model-fitting in second step. The
model fitting is used to distinguish SNPs that have joint
effects from those SNPs that only have marginal effects.
Due to the feature of randomization technique,
SNPHarvester is expected to perform no better than
exhaustive search. Since there are numerous local
optimal paths, the performance of the filtering step
is poor, which leads to little power to detect the
ground-truth interactions. Comparing to brute-force
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approaches, SNPHarvester is suitable to detect
three-way or higher-order epistatic interactions.
SNPHarvester focuses only on eNME, because it
utilizes the L2 penalizes logistic regression model.
4.3.2 epiMODE

epiMODE spends too much time on the iteration
of the reversible jump Markov chain Monte Carlo
procedure. Another drawback of epiMODE is that it has
no ability on datasets with 5% genotyping error, which
is common in real GWAS datasets.

Tang et al.[55] developed an extension of BEAM
using the Gibbs sampling strategy, named epiMODE,
to facilitate the detection of epistatic modules. In
epiMODE, the epistatic interaction module is
considered as the basic units of disease susceptibility
loci that independently influence the phenotype. On
the basis of this notion, it adopts a Bayesian marker
partition model to explain the observed case-control
data, and further generalizes this model to account
for the existence of LD between genetic variants. The
genetic variants (SNPs) belonging to a epistasis
module are simulated in a procedure, called Reversible
Jump MCMC (RJ-MCMC), based on Gibbs sampling
strategy. Further hypothesis testing is applied to screen
out statistically significant modules.
In epiMODE, the penetrance of the combinatory
genotypes of two subsets, S1 and S2 , of SNPs can be
described as
p.DjGS1 ; GS2 / D f .GS1 ; GS2 /;
where G represents a combinatory genotype of the
multiple loci, and f . / is the function denoting
how combinatory genotypes determines the disease
penetrance. If
p.DjGS1 ; GS2 / D f .GS1 ; GS2 / D f1 .GS1 /f2 .GS2 /;
is always true, the relationship between the two
subsets of loci S1 and S2 is defined as “independently
contributing” to the disease. Otherwise, the relationship
between them is defined as “epistasis”. With these
concepts, the problem of finding epistatic interactions
was equivalent to a problem of assigning the SNP
markers to the defined modules. Particularly, the
assignment for an SNP can be done by first calculating
the probability of the observed data given a certain
partition pattern using a Bayesian model. epiMODE
assumes that all loci are in LD, also known as
independent. It uses first-order Markov model to
account for the situation in which a set of SNPs are
in LD with a disease susceptibility. Finally, epiMODE
resorts to hypothesis testing to screen out significant
epistatic interactions.
As discussed in recent reviews, a weakness of
epiMODE is that it can not deal with datasets with more
than 10 000 SNPs in affordable time[25] . Obviously,

4.4

Heuristic searching methods for detecting
epistatic interactions

Heuristics approaches adopt machine learning
techniques, such as neural networks and predictive
rules, to search the space of epistatic interactions
rather than explicitly enumerating and testing all the
combinations of k-locus. The overview and resource
information of method falling into heuristic search is
shown in Table 5. Two examples falling into this field
are MECPM and MIC. MECPM proposes a phenotype
posterior under a maximum entropy principle, and uses
greedy searching to find epistatic interactions which
are treated as model constraints. MIC is a model-free
method which defines significant tests based on mutual
information, and uses k-means clustering to narrow
down the candidate groups.
4.4.1

MECPM

Miller et al.[60] proposed a method, named MECPM,
to identify markers/interactions by building the
Table 5

Heuristic search methods for detecting epistasis.
Model-based

MECPM

GPNN
CMM

Maximum Entropy Conditional Probability
Modelling (2009)[60] , http://www.cbil.ece.
vt.edu/ResearchOngoingSNP.htm
Genetic Programming optimized Neural
Network (2006)[61]
Tree and spline based association analysis
(2004)[62] , http://lib.stat.cmu.edu/
Model-free

[1mm]
epiMiner
MIC
DPM
AES
SNPRuler

AGR
MSH
RST
TWG

epistasis Miner (2014)[63] , https://sourceforge.
net/projects/epiminer/files/
Mutual Information (2014)[64]
Discriminative Pattern Mining (2012)[65]
AntEpiSeeker (2010)[66] , http://nce.ads.uga.edu/
romdhane/AntEpiSeeker/index.html
Predictive rule inference for epistatic
interaction detection (2010)[67] ,
http://
bioinformatics.ust.hk/SNPRuler.zip
Association Graph Reduction (2009)[68]
MegaSNPHunter (2009)[69]
Rough Set Theory (2009)[70]
Trimming, Weighting and Grouping (2001)[71] ,
http://linkage.rockefeller.edu/ott/sumstat.html
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phenotype-predictive models. MECPM treats the
problem as a supervised feature selection in statistical
classification where “cases” and “controls” are two
classes. The goal is to select the feature subset which
leads to the best classification performance. According
to the principle of Maximum Entropy (ME), a
probability model should agree with all known
information and remain maximal uncertainty[72] . In
the ME framework, a posterior model (classifier) is
defined by the interactions to satisfy the specified
constraints and maximize the conditional entropy
at the same time. Without any constraint, the ME
posterior is a uniform probability mass function over
all classes, and the accuracy of the resulting model is
compromised. Each encoded constraint reduces the
(maximum) entropy, which yields a more predictive
posterior. The importance of constraint is measured by
the decreased amount of the ME distribution’s entropy
by applying the constraint. The ME optimization
problem is convex with linear constraints, and the
standard solutions guarantee to the convergence.
A variant of greedy search based on Bayesian
Information Criterion (BIC) is used for choosing
the ME constraints (interactions up to five-way)
when model grows, and determining the number of
constraints to terminate the model growing. BIC is a
model selection criterion that it captures a trade-off
between data likelihood and model complexity among a
finite set of models. In the seed selection and accretion
of constraints, MECPM measures the Kullback-Leibler
divergence[73] between the probability mass functions
for all possible one- and two-way SNP constraints. It
shows that at a given order, the constraints, which are
furthest from the existing model, will decrease BIC cost
the most if they are added to the model. Therefore, an
alternative to accretion of all possible constraints is to
use seed pool, which comprises the constraints with
largest Kullback-Leibler divergence at first and second
orders, and MECPM adds one constraint at a time.
MECPM builds the phenotype posterior under a
maximum entropy principle, and encodes constraints
into the model with a 1-to-1 correspondence to the
epistatic interactions. From the experimental results,
the time complexity is considerably high that it took
750 hours and 7.5 hours to detect five- and two-way
interaction for a dataset with only 1000 SNPs and 2000
balanced samples. Another flaw of MECPM is that it
does not give any significance assessment, and thus it
is hard to tell the types of reported epistatic interactions
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(eME or eNME).
4.4.2 MIC
Leem et al.[64] proposed an algorithm (MIC) based on
mutual information for detecting high order epistatic
interactions in GWAS. As claimed by the authors,
mutual information does not suffer the approximation
issue as other statistic tests. Take Pearson’s 2 test
for example, the approximation to the 2 distribution
breaks down, if the expected frequencies are too
low. The issue can be even worse when we detect
higher order epistatic interactions. Mutual Information
I.SI Y / is defined to capture the amount of the
information shared by two random variables, S and
Y . Let S denote a subset of L SNPs, and Y denote
the class labels. MIC uses the value of I.S I Y / to
imply the significance of the association between
the SNP combination and the disease. Let A D
fA1 ; A2 ;    ; An g be a partition of S. The entropy
H.A/ of A is defined as follows:
n
X
jAi j
jAi j
log
:
H.A/ D
L
L
iD1

Then the mutual information between the joined
partition fA.1/ ; A.2/ ;    ; A.k/ g and a partition Y can be
defined as follows:
I.A.1/ ; A.2/ ;    ; A.k/ I Y / D H.A.1/ ; A.2/ ;    ; A.k/ / C
H.Y / H.A.1/ ; A.2/ ;    ; A.k/ I Y /;
where H.A.1/ ; A.2/ ;    ; A.k/ / is the extension of
H.A/ to multiple partition. Based on the definition of
mutual information, MIC tries to find the set of k SNPs
that maximized the value I.A.1/ ; A.2/ ;    ; A.k/ I Y /.
Since the size of current GWAS data can reach
up to hundreds of thousands of SNPs, it takes too
much time to calculate the I.A.1/ ; A.2/ ;    ; A.k/ I Y /
for every k-modules (k > 3). Therefore, MIC uses kmeans clustering to reduce time complexity by placing
strongly interacting SNPs into different clusters. MIC
can be separated into three steps: clustering, candidates
selection, and finding the k-SNP module with high
mutual information value. The summary of three steps
is as follows:
 Step 1 k-means clustering is used on the set
of SNPs with the distance measured by mutual
information between two SNPs.
 Step 2 Top d SNPs are selected in each cluster
according to their scores, which is calculated as
the sum of all mutual information values measured
between the selected SNP to the rest SNPs in the
same cluster.
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 Step 3 MIC exhaustively searches k SNP
modules with the highest value of mutual
information among kd candidates.
An explicit advantage of MIC is that the speed of
algorithm is very fast since k-means takes linear time to
do the clustering, and the exhaustive search can be done
fast when f is small. However, MIC does not display
its false control rate under the null hypothesis, so the
significance of reported interaction is unclear. Based
on the experimental results of MIC, it shows power to
detect eME and eNME, although it cannot distinguish
the types of reported modules.

5

Evaluation Methodology

The methods for searching epistatic interactions in
GWAS should be evaluated not only with small
simulated datasets, but also with large and complicated
real datasets. In the experiments of the simulated
data, different disease models with or without marginal
effects should be embedded into the datasets. In the
experiments of real data, well-studied GWAS projects
with established epistatic interactions can be employed
as standard measurement. In order to evaluate and
compare the statistic power of existing methods, more
than one metrics should be considered. In the following
sections, definitions of five popular power metrics
are given. Then we list multiple disease models with
or without marginal effects for simulation. Several
real GWAS projects with links to the resource are
also provided. Finally, we discuss the control of
false discovery rate, and summarize the general
advantages and disadvantages of existing methods in
seven categories.
5.1

Detection powers

Detection power can be defined in several ways,
depending on what we desire to measure. Before
giving the definitions of detection power, several
terms and notations should be introduced. Since a
complex disease may be caused by multiple epistatic
interactions, each of which consists of one or more
SNPs, it is necessary to simulate multiple epistasis
models in a dataset. Suppose that we generate W
datasets with the same parameter settings, i.e., the
embedded epistatsis models have the same number of
SNPs and the same values of parameters. For the i th dataset, we use ci to denote the count of epistasis
models, and xij to denote the number of SNPs involved
in model j . The total number of ground-truth SNPs

for i -th dataset is Ci D

ci
X

xij . Usually, the method

j D1

returns a ranked list of SNPs or SNP combinations,
which implies their descending importance. Since the
statistical significance increases as the number of SNPs
in one model increases, it is difficult to compare
the importance of modules with uneven number of
SNPs. Therefore, we set ci to a fixed value k > 2, and
we assume that it is able to get top i SNPs from the
methods for the i -th dataset.
 Precise Power (PP) is defined as the proportion of
datasets in which all ground-truth SNPs are ranked
at highest by a method. This power definition
evaluates the sensitivity to detect the interaction as
a whole. It is written as
W
1 X
PP D
zPP;i ;
W
i D1

where zPP;i 2 f0; 1g is the detection indicator, i.e.,
if the detected set of top i (i D Ci ) SNPs only
consists of ground-truth SNPs in the i -th dataset,
zPP;i D 1; otherwise, zPP;i D 0.
 Average Power (AP) is defined as an average
proportion of true positives in the top i (i D Ci )
SNPs. It is written as
W ci
jxij \ i j
1 XX
AP D
;
W
xij
i D1 j D1

where jxij \i j is the number of ground-truth SNPs
in the top i SNPs identified in the i -th dataset.
 Extended Power (EP) is defined as the ratio of
the number of ground-truth SNPs appearing in the
top i (i > Ci ) SNPs for the i -th dataset by a
method. It can be written as
ci
W
1 X 1 X
ji \ xij j;
EP D
W
Ci
i D1

j D1

where ji \xij j is the number of ground-truth SNPs
in the top i (i > Ci ) SNPs detected in dataset i
for j -th epistatsis model.
 General Power (GP) is defined as the percentage of
W datasets in which at least 1 ground-truth SNPs
is identified in the top i SNPs for all embedded
models in a dataset. It is written as
W
1 X
GP D
zGP;i ;
W
i D1

where zGP;i 2 f0; 1g is the detection indicator, i.e.,
if the detected set of top i SNP consists at least
on ground-truth SNPs for all embedded models in
dataset i , zGP;i D 1; otherwise, zGP;i D 0.
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 Receiver Operating Characteristic (ROC) curve
is a graphical plot showing how many groundtruth SNPs detected for a given false positive
SNP count. It is generated by plotting the fraction
of true positives out of the total actual positives
vs. the fraction of false positives out of the total
actual negatives at various threshold settings[74] .
5.2

Simulated disease models

There is a wide spectrum of epistases. Some show
both marginal (main) effects and interactive effects,
and others show no marginal effects but interactive
effects. We refer to the former as eME and the latter
as eNME[25] . A disease model can be defined either by
specifying the penetrance table or the odds table. Let
p .Djgi / denote the probability that an individual
will be affected with a given genotype combination
gi . Relations among penetrance p .D/, odds ODDgi ,
and p .Djgi / can be calculated as Eqs. (4) and (5).
p .Djgi /
p .Djgi /
ODDgi D
D
(4)
1 p .Djgi /
p.Djgi /
ODDgi
(5)
1 C ODDgi
In Ref. [20], the disease prevalence p.D/ and genetic
heritability h2 are given by Eqs. (6) and (7).
X
(6)
p .D/ D
p .Djgi / p .gi /
p .Djgi / D

i

X
h2 D

.p .Djgi /

p .D//2 p .gi /

i

(7)
p .D/ .1 p .D//
As introduced in Ref. [13], the marginal odds at locus
A for two-locus epistasis model containing locus A and
B are defined by
X
p.DjgA ; gB /p.gB /
p.DjgA /
gB
;
DX
p.DjgA /
p.DjgA ; gB /p.gB /

examples of epistasis models with or without marginal
effects in the following paragraphs.
 Models with marginal effects. We consider four
two-loucs epistasis models whose odds tables are
given in Table 6. Model 1 is a multiplicative
model. Model 2 is an epistasis model that
has been used to describe handedness and the
color of swine. Model 3 is a classical epistasis
model. Model 4 is the well known XOR (exclusive
OR) model. Two three-locus epistasis models are
shown in Tables 7 and 8. In Model 5, increased
disease risk is assigned to certain genotype
combinations, and marginal effect of each disease
locus ranges from very small to zero. Model 6 is a
three-locus model, and it achieves the maximum
heritability
at

 the low end of disease prevalence
1
( 2 0;
).
16
Table 6

Odds tables of epistasis models 1, 2, 3, and 4.
BB
˛
˛
˛

Model 1
AA
Aa
aa

Bb
˛
˛.1 C /
˛.1 C /2

bb
˛
˛.1 C /2
˛.1 C /4

Model 2
AA
Aa
aa

BB
˛
˛.1 C /
˛.1 C /

Bb
˛.1 C /
˛
˛

bb
˛.1 C /
˛
˛

Model 3
AA
Aa
aa

BB
˛
˛
˛.1 C /

Bb
˛
˛.1 C /
˛

bb
˛.1 C /
˛
˛

Model 4
AA
Aa
aa

BB
˛
˛.1 C /
˛

Bb
˛.1 C /
˛
˛.1 C /

bb
˛
˛.1 C /
˛

Table 7

gB

where p.DjgA ; gB / is the probability that an individual
has the disease given that they have a combination of
genotype gA at locus A and genotype gB at locus B. For
each model, the parameter  is used to measure the
marginal effect size, which is written as follows.
p.Djsa D 0/ p.Djsa D 1/
D
=
1;
p.Djsa D 0/ p.Djsa D 1/
where 0 and 1 are the genotypes at locus A used in the
Section 4. Based on the marginal effect size, if  D
0, the model displays no marginal effects; otherwise,
the model has marginal effects. We describe several
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Odds table of epistasis model 5.

AA
Aa
aa

BBC C
˛
˛
˛

BbC C
˛
˛
˛.1 C /

bbC C
˛
˛.1 C /
˛

AA
Aa
aa

BBC c
˛
˛
˛.1 C /

BbC c
˛
˛.1 C ˇ/
˛

bbC c
˛.1 C /
˛
˛

AA
Aa
aa

BBcc
˛
˛.1 C /
˛

Bbcc
˛.1 C /
˛
˛

bbcc
˛
˛
˛
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Table 8

AA
Aa
aa

BB
0
0
0

Penetrance table of epistasis model 6.

CC
Bb bb
0
16
0
0
0
0

BB
0
0
0

Cc
Bb
0
4
0

bb
0
0
0

BB
0
0
16

cc
Bb
0
0
0

Table 9
bb
0
0
0

 Models without marginal effects. Disease models
displaying no main effects have been carefully
discussed, and a wide spectrum of these models
have been provided[75] . Velez et al.[75] generated
a total of 70 different penetrance functions
that define a probabilistic relationship between
genotype and phenotype. The susceptibility to
disease is dependent on genotypes from two loci
in the absence of any marginal effects. A total
of five models for each of the 14 heritabilityallele frequency combinations were generated
for a total of 70 models. The details of the
70 penetrance functions are available online
(http://discovery.dartmouth.edu/epistatic data/).
In the simulation, we have two ways to numerically
solve the parameters (˛ and  ): either (1) specify the
disease prevalence p.D/, the genetic heritability h2 ,
and Minor Allele Frequency (MAF), or (2) fix the
MAFs and marginal effect size . A detail depiction of
the simulation process is available in Ref. [53].
5.3

Real GWAS data

In order to evaluate the performance of the method
for identifying epistatic interactions truly involving
biological processes, we need to test the methods
on well studied GWAS datasets. In Table 9, we
list 11 GWAS datasets with their references. The
Wellcome Trust Case Control Consortium (WTCCC) is
a collaboration of many British research groups. The
genetic signals of seven common human diseases have
been examined in the first phase of WTCCC. Take
the disease AMD for example, it is the leading
cause of blindness for people over 50, and it is a
common eye disease that is associated with aging
and gradually destroys sharp, central vision. For the
AMD dataset, Klein et al.[76] reported two SNPs
(rs380390 and rs1329428) that were associated with
AMD. Therefore, it is reasonable to tell the performance
of methods whether these two SNPs have been reported
by proposed methods. In addition, it is interesting to
compare the results generated by new methods with the
results from existing tools to check novel findings.

Real GWAS datasets.

Name

SNP
AMD (Age-related Macular 116 204
Degeneration)
CD (Crohn’s Disease)
317 503
LOAD (Late-Onset AD)
502 627
RA (Rheumatoid Arthritis) 545 080
WTCCC
RA (Reumatoid Arthritis) 459 012
HT (HyperTension)
459 012
CD (Crohn’s Disease)
459 012
CAD (Coronary Artery 459 012
Disease)
BD (Bipolar Disorder)
459 012
T1D (Type 1 Diabetes)
459 012
T2D (Type 2 Diabetes)
459 012

5.4

Number
Case Con.
96
50

Ref.
[76]

513
861
868

515
550
1194

[77]
[78]
[79]

1860
1952
1748
1926

2983
2983
2983
2983

[80]

1868
1963
1924

2983
2983
2983

False discovery rate control

False Discovery Rate (FDR) control is used in multiple
hypothesis testing to correct for multiple comparisons.
In a list of findings (i.e., studies where the nullhypotheses are rejected), FDR procedures are designed
to control the expected proportion of incorrectly
rejected null hypotheses (“false discoveries”)[81] . In the
detection of epistatic interactions, there are two popular
procedures for FDR control: permutation test and
Bonferroni correction, of which the brief introductions
are given in the following paragraphs.
5.4.1

Permutation test

Without a normal assumption for the distribution of
data, like genome-wide case-control data, permutation
test is an effective non-parametric approach to establish
the null distribution of a test statistic. In GWAS, two
hypotheses need to be tested: H0 , the module is
not associated with the disease; H1 , the module is
associated with the disease. The following procedures
can be applied for permutation test in detecting genegene interactions:
 Step 1 Use the proposed method to the original
case-control data with the appropriate parameter
setting, list the candidate epistatic modules in
order of their significance indicators, like p-value.
 Step 2 Generate new case-control data by
shuffling individuals’ labels between case and
control, apply the method with the same parameter
setting to the newly permuted data, and record the
value of indicator which is most significant from
the reported epistasis modules.
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 Step 3 Repeat Step 2 for ! times, and make a list
of ! significance indicators.
 Step 4 For each candidate epistasis module
generated using the original case-control data,
record how many significance indicators from
permuted data are more significant than the current
candidate module. The quotient using this count
divided by ! is the p-value of permutation test
for the candidate module by employing proposed
method.
Usually, we set ! D 1000. By giving a significant
level ˛ D 0:05, we remove the non-significant epistatic
interactions if their p-values from permutation test are
larger than ˛.
5.4.2

Bonferroni correction

In statistics, the Bonferroni correction is a method used
to counteract the problem of multiple comparisons. The
Bonferroni correction is based on the idea that if an
experimenter is testing n dependent or independent
hypotheses on a set of data, the probability of type I
error is offset by testing each hypothesis at a statistical
1
significance level
times what it would be if only
n
one hypothesis is tested. For example, given a GWAS
dataset with L SNPs, the adjusted p-value of reported
epistatic interaction is calculated by multiplying the
number of tests. For detecting two-locus interactions,
the number of tests is L.L 1/=2, and for detecting
three-locus interactions, the number of tests is L.L
1/.L 2/=6.
5.5

Table 10 The advantages and disadvantages of existing
method for searching epistatic interactions.

A

D

A

D

A
D

A

Advantages and disadvantages

All eight methods reviewed in this paper have
demonstrated respective utilities based on the
experimental results conducted in the recent
literatures[25, 64, 82] . We summarize their merits and
weaknesses in Table 10. For the exhaustive methods,
since they enumerate and test all possible combinations
of k-locus, it can report all significant epistasis
without losing any power. An explicit drawback of
exhaustive search is the intensive computation. In order
to accelerate the process, finding an approximation
with less intensive computation for calculating the
significance value is a possible solution, but it will lose
power. Instead of testing all the k-locus combinations of
SNPs, stepwise, stochastic, and heuristic searches only
select a subset of SNPs for further tests. A common
disadvantage of them is the power lost. As shown in a
recent theoretical study[41] , the possibility that a high-
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D

Model-based
Model-free
Exhaustive search
High power;
Low complexity for single
significant test;
Discrimination of eME and Enumerating
two-locus
eNME
tests is computational
possible.
Time consuming in model No discrimination on the
fitting if the size of SNP model types
module k > 3;
Power lost if using
approximation test
Stepwise search
Discrimination of eME and Low complexity for single
eNME
significant test;
The size of tested SNP
module can reach up to 5.
Power lost if the higher-order modules displaying
insignicant marginal effects;
Time consuming if the screening process is
complicated.
Stochastic search
Performance is good if SNP models display strong
marginal effects.
Power lost if model cannot capture the relationship;
Time consuming if the number of iteration for sampling
is huge.
Heuristic search
High power for GWAS data Low complexity for single
with moderate size
significant test;
Screening
process
is
efficient.
Power lost if model cannot Power lost if the highcapture the relationship;
order modules displaying
insignicant
marginal
effects;
Time
consuming
if Lack of controlling of false
model
building
is discovery rate.
compuatationally intensive.

Note: A, stands for advantage; D, stands for disadvantage;  , all
stochastic search methods in this review are belonging to modelfree category.

order (size-k) combination with strong differentiation
displaying zero differentiation in all of its subsets
decreases dramatically when k increases (generally
become impossible for k greater than 5). Based on the
above theory, stepwise methods usually exhaustively
test all two-locus interaction, and select top-d SNPs for
higher-order tests. The scalability of stepwise methods
is good if one single test can be done very fast, like
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EDCF[48] . Stochastic methods use random sampling
procedures to search the space of interactions. The key
factor influencing the performance of stochastic method
is the selection of sampling procedure. As shown in
the experimental results from recent literatures[25, 64, 82] ,
stochastic methods lose more power than the other three
strategies, and the execution of stochastic methods is
time consuming if the number of iteration of sampling
is large for huge GWAS data. Heuristics approaches
utilize machine learning techniques, such as neural
networks and predictive rule, to search the space
of epistatic interactions. Most heuristic methods are
running very fast compared to the proceeding three
strategies. However, most of them lack the control
of FDR, and thus it is difficult to tell how good they
are without control of type I error, and to avoid false
epistatic interactions.

general, SNPs in coding regions, termed as nonsynonymous SNPs, may have a greater impact on the
gene function than those in non-coding regions. The
non-synonymous SNPs may cause pathological
consequences either by affecting the 3-D conformation
of protein structure or their corresponding active
domains. Consequently they can potentially disrupt
the recruitment scaffold of corresponding protein. The
epigenome consists of a record of histone modifications
and DNA methylation of an organism. There are
some evidences of correlation between SNPs and the
quantitative traits of DNA methylation[83-85] . Therefore,
how to integrate the region information of SNPs and
the changes on epigenome into the detection of diseaseassociated epistatic interactions will be a promising
and challenging direction in genome-wide association
studies.
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Summary and Outlook

As we have seen, there are numerous methods and
an even larger number of software implementations
allowing investigators to examine disease-associated
epistatic interaction based on available GWAS
data generated from large-scale genotyping
projects. Although the precise details of the methods
are different, in many cases there are closely conceptual
links between the approaches. Existing methods for
searching epistasis can be grouped into two types,
model-based and model-free by considering the
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four types, i.e., exhaustive, stepwise, stochastic, and
heuristic approaches. In this review, we identify 43
methods for detecting disease-associated epistatic
interactions. Eight of them are discussed in details in
the paper. The evaluation methodologies for searching
epistasis are elaborated, including five definitions of
detecting power, disease models for simulating dataset,
resources of well studied real GWAS datasets, and the
control for FDR. Finally, we generally summarize the
advantages and disadvantages of popular GWAS tools.
Current approaches merely focus on the relationship
between genotypes and the phenotype traits. However,
more information, like SNP positions on the
chromosomes and suspicious epigenome patterns,
can be helpful to construct a systematically causal
relation behind the diseases. SNPs are found in coding
areas as well as in the non-coding regions of genes. In
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